Skip to main content

Advertisement

SpringerLink
Log in

New therapies in development for autoimmune diseases: their rationale for combination treatment

  • General Section
  • Published:
Springer Seminars in Immunopathology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Abrams JR, Lebwohl MG, Guzzo CA, Jegasothy BV, Goldfarb MT, Goffe BS, et al (1999) CTLA4Ig-mediated blockade of T cell costimulation in patients with psoriasis vulgaris. J Clin Invest 103: 1243

    Article  PubMed  CAS  Google Scholar 

  2. Alcocer-Varela J, Llorente L, Alarcon-Segovia D (1996) Immunoregulatory circuits and potential treatment of connective tissue diseases. Int Arch Allergy Immunol 111: 348

    Article  PubMed  CAS  Google Scholar 

  3. Al-Janadi M, Al-Dalaan A, Al-Balla S, et al (1996) IL-10 secretion in systemic lupus erythematosus and rheumatoid arthritis: IL-10 dependent CD4+CD45RO T cell-B cell antibody synthesis. J Clin Immunol 16:198

    Article  PubMed  CAS  Google Scholar 

  4. Apparailly F, Verwarde C, Jacquet C, et al (1998) Chondroprotective effect of gene transfer of IL-10 in type I collagen-induced arthritis. J Immunol 160: 5213

    PubMed  CAS  Google Scholar 

  5. Badger A, Swift B, Rieman D, Stroup G, et al (1999) Effect of SB273005, an orally active, non-pep-tide avb3 vitronectin receptor antagonist in the adjuvant arthritic rat. Arthritis Rheum 42: s118

  6. Barnes DA, Tse J, Kaufhold M, et al (1998) Polyclonal antibody directed against human RANTES ameliorates disease in the Lewis rat adjuvant-induced arthritis model. J Clin Invest 101: 2910

    Article  PubMed  CAS  Google Scholar 

  7. Barnett ML, Kremer JM, St. Clair EW, et al (1998) Treatment of rheumatoid arthritis with oral type II collagen: Results of a multicenter, double-blind, placebo-controlled trial. Arthritis Rheum 41: 290

    Article  PubMed  CAS  Google Scholar 

  8. Bendele AM, Chlipala ES, Rich WR, Edwards CK (1999) Combination benefit of treatment with recombinant IL-Ira and pegylated recombinant human soluble TNF-R type I on animal models of rheumatoid arthritis. Arthritis Rheum 42: S171

  9. Beutler B (1995) TNF, immunity and inflammatory disease: lessons of the past decade. J Invest Med 43:227

    CAS  Google Scholar 

  10. Burger D, Rezzonico R, Li J-M, Modoux C, et al (1998) Imbalance between interstitial collagenase and tissue inhibitor of metalloproteinases 1 in synoviocytes and fibroblasts upon direct contact with stimulated T lymphocytes. Arthritis Rheum 41:1748

    Article  PubMed  CAS  Google Scholar 

  11. Chuzhin Y, Reddy B, Budhai L, et al (1998) Prolonged survival in murine SLE by adenoviral mediated CTLA41g gene transfer. Arthritis Rheum 41: S140

  12. Daikh DI, Finck BK, Linsley PS, et al (1997) Long-term inhibition of murine lupus by brief simultaneous blockade of the B7/CD28 and CD40/gp39 costimulation pathways. J Immunol 159:304

    Google Scholar 

  13. Davidson A, Budhai L, Reddy B, Viashnaw A, Furie R (2000) The effect of anti-CD40L on B cells in human SLE. Arthritis Rheum 43:S271

    Google Scholar 

  14. Davis JC, Totoritis MC, Sklenar TA, Wofsy D (1999) Results of a phase I single dose dose escalating trial of a humanized antiCD40L monoclonal antibody (IDEC 131) in patients with SLE. Arthritis Rheum 42:S281

    Google Scholar 

  15. Davis L, Kavanaugh AF, Nichols LA, Lipsky P (1995) Induction of persistent T cell hyporesponsiveness in vivo by monoclonal antibody to ICAM-1 in patients with rheumatoid arthritis. J Immunol 154: 3525

    PubMed  CAS  Google Scholar 

  16. De Waal Malefijt R, Chromarat P, Vannier E, et al (1995) Balance of IL-1 receptor antagonist/IL-lB in rheumatoid synovium and its regulation by IL-4 and IL-10. J Immunol 154: 1432

    Google Scholar 

  17. Dinarello CA, Wolff SM (1993) The role of interleukin-1 in disease. N Engl J Med 328:106

    Article  PubMed  CAS  Google Scholar 

  18. Evans C, Ghivizzani SC, Kang R, Muzzonigro, et al. (1999) Gene therapy for rheumatic diseases. Arthritis Rheum 42: 1

    Article  PubMed  CAS  Google Scholar 

  19. Feige U, Campagnuolo G, Cheng Y, Bolon B (1999) Osteoprotegerin decreases bone resorption in adjuvant arthritis in Lewis rats. Arthritis Rheum 42:S120

    Google Scholar 

  20. Feige U, Hu YL, Julian E, Duryea D, Bolon B (1999) Combining anti-IL-1 and anti-TNF treatments provides better efficacy in rat adjuvant arthritis than does either agent alone. Arthritis Rheum 42:S383

    Google Scholar 

  21. Finck BK, Linsley PS, Wofsy D (1994) Treatment of murine lupus with CTLA41g. Science 265:1225

    Article  PubMed  CAS  Google Scholar 

  22. Firestein GS, Escheverri F, Yeo M, et al (1996) Somatic mutations in the P53 tumor suppressor gene in rheumatoid arthritis (RA) synovium. J Clin Invest 96: 1631

    Article  Google Scholar 

  23. Foy TM, Aruffo A, Bajorath J, Buhlmanin JE, Noelle RJ (1996) Immune regulation by CD40 and its ligand of p39. Annu Rev Immunol 14: 591

    Article  PubMed  CAS  Google Scholar 

  24. Fujisawa K, Asahara H, Okamoto K, et al (1996) Therapeutic effects of the anti-Fas antibody on arthritis in the HTLV-l tax transgenic mice. J Clin Invest 98: 271

    Article  PubMed  CAS  Google Scholar 

  25. Gaur A, Fathman CG (1994) Immunotherapeutic strategies directed at the trimolecular complex. Adv Immunol 56:219

    Article  PubMed  CAS  Google Scholar 

  26. Gerlag DM, Bprges E, Ellerby HM, et al (1999) Targeted apoptosis of synovial neovasculature in murine collagen induced arthritis. Arthritis Rheum 42:S120

    Google Scholar 

  27. Ghivizzani SC (1998) Direct adenovirus-mediated gene transfer of interleukin 1 and tumor necrosis factor alpha soluble receptors to rabbit knees with experimental arthritis has local and distal anti-arthritic effects. Proc Natl Acad Sei USA 95:4613

    Article  CAS  Google Scholar 

  28. Gong JH, Ratkey LG, Waterfield JD, et al (1997) An antagonist of monocyte chemoattractant protein 1 (MCP-1) inhibits arthritis in the MRL-Lpr mouse model. J Exp Med 186:131

    Article  PubMed  CAS  Google Scholar 

  29. Gracie JA, Forsey RJ, Chan WL, Gilmour A, Leung BP, et al (1999) A proinflammatory role for IL-18 in rheumatoid arthritis. J Clin Invest 104:1393

    Article  PubMed  CAS  Google Scholar 

  30. Grammer AC, Bergman MC, Miura Y, et al (1995) The CD40 ligand expressed by human B cells co-stimulates B cell responses. J Immunol 154:4996

    PubMed  CAS  Google Scholar 

  31. Grewal IS, Flavell RA (1996) A central role of CD40 ligand in the regulation of CD4-T cell responses. Immunol Today 17: 410

    Article  PubMed  CAS  Google Scholar 

  32. Grondal G, Kristjansdottir H, Traustadottir KH, et al (1998) IL-10 production and apoptosis in SLE patients and their spouses in icelandic SLE-multicase families. Arthritis Rheum 41: S283

  33. Guinan EC, Boussiotis VA, Neuberg D, Brennan LL, Hirano N, et al (1999) Transplantation of anergic histoincompatible bone marrow allografts. N Engl J Med 340:1704

    Article  PubMed  CAS  Google Scholar 

  34. Haqqi TM, Qu X-M, Anthony D, Ma J, Sy M-S (1996) Immunization with T cell receptor Vb chain peptides deletes pathogenic T cells and prevents the induction of collagen-induced arthritis in mice. J Clin Invest 334:395

    Google Scholar 

  35. Hermann JA, Hall MA, Maini RN, Feldmann M, Brennan FM (1998) Important immunoregulatory role of IL-11 in the inflammatory process in RA. Arthritis Rheum 41:1388

    Article  PubMed  CAS  Google Scholar 

  36. Iigo Y, Takashi T, Tamatani T, et al (1991) ICAM-1 dependent pathway is critically involved in the pathogenesis of adjuvant arthritis in rats. J Immunol 147:4167

    PubMed  CAS  Google Scholar 

  37. Ishida H, Muchamuel T, Sakaguchi S, et al (1994) Continuous administration of anti-interleukin 10 antibodies delays onset of autoimmunity in NZB/W Fl mice. J Exp Med 179:305

    Article  PubMed  CAS  Google Scholar 

  38. Jasen HE, Lightfoot E, Davis LS, et al (1992) Amelioration of antigen-induced arthritis in rabbits treated with monoclonal antibodies to leukocyte adhesion molecules. Arthritis Rheum 35:541

    Article  Google Scholar 

  39. Joosten LAB, Lubberts E, Durez P, et al (1997) Role of IL-4 and IL-10 in murine collagen induced arthritis: protective effect of IL-4 and IL-10 treatment on cartilage destruction. Arthritis Rheum 40:249

    Article  PubMed  CAS  Google Scholar 

  40. Kakimoto K, Nakamura T, Ishii K, et al (1992) The effect of anti-adhesion molecule antibody on the development of collagen-induced arthritis. Cell Immunol 142:326

    Article  PubMed  CAS  Google Scholar 

  41. Kalden JR, Sieper J (1998) Oral collagen in the treatment of rheumatoid arthritis. Arthritis Rheum 41:191

    Article  PubMed  CAS  Google Scholar 

  42. Kalled SL, Cutler AH, Datta SK, Thomas DW (1998) Anti-CD40 ligand antibody treatment of SNF1 mice with established nephritis: preservation of kidney function. J Immunol 160:2158

    PubMed  CAS  Google Scholar 

  43. Kalunian K, Davis J, Merrill JT, et al (2000) Treatment of SLE by inhibition of T cell costimulation. Arthritis Rheum 43: S271

  44. Kanakami A, Eguchi K, Matsuoka N, et al (1997) Inhibitory effects of interleukin-10 in rheumatoid arthritis. Immunology 91: 252

    Article  Google Scholar 

  45. Kasama T, Strieter RM, Lukacs NW, et al (1995) Interleukin 10 expression and chemokine regulation during the evolution of murine type II collagen induced arthritis. J Clin Invest 95:2868

    Article  PubMed  CAS  Google Scholar 

  46. Kavanaugh A, Davis LS, Jain R, et al (1996) A phase I/II open label study of the safety and efficacy of an anti-ICAM-1 (intercellular adhesion molecule-1; CD54) monoclonal antibody therapy in early rheumatoid arthritis. J Rheumatol

  47. Kavanaugh AF, Davis LS, Nichols LA, et al (1994) Treatment of refractory rheumatoid arthritis with a monoclonal antibody to intercellular adhesion molecule-1. Arthritis Rheum 37:992

    Article  PubMed  CAS  Google Scholar 

  48. Koch AE (1998) Angiogenesis: implications for rheumatoid arthritis. Arthritis Rheum 41:951

    Article  PubMed  CAS  Google Scholar 

  49. Kohno K, Kurimoto M (1998) IL-18, a cytokine which resembles IL-1 structurally and IL-12 functionally but exerts its effect independently of both. Clin Immunol Immunopathol 86: 11

    Article  PubMed  CAS  Google Scholar 

  50. Lenschow DJ, Walunas TL, Bluestone JA (1996) CD28/B7 system of T cell co-stimulation. Annu Rev Immunol 14: 233

    Article  PubMed  CAS  Google Scholar 

  51. Llorente L, Richaud-Patin Y, Garcia-Padilla C, et al (2000) Clinical and biological effects of anti-in-terleukin-10 monoclonal antibody administration in systemic lupus erythematosus. Arthritis Rheum 43:1790

    Article  PubMed  CAS  Google Scholar 

  52. Llorente L, Zou W, Lewy Y, et al (1995) Role of interleukin-10 in the B lymphocyte hyperactivity and autoantibody production of human systemic lupus erythematosus. J Exp Med 181:839

    Article  PubMed  CAS  Google Scholar 

  53. Lockwood CM, Elliott JD, Brettman L, Hale G, Rebello P, Frewin M, Ringler D, Merril C, Waldmann H, Clin Immunol 93:93

  54. Lubberts E, Joosten LAB, Bersselaar L van den, et al (1999) Adenoviral vector-mediated overexpression of IL-4 in the knee joint of mice with collagen induced arthritis prevents cartilage destruction. J Immunol 163:4546

    PubMed  CAS  Google Scholar 

  55. Ma Y, Duwel L, Thornton S, et al (1997) Viral IL-10 gene therapy inhibits collagen-induced arthritis in mice. Arthritis Rheum 40: S158

  56. Maini RN, Paulus H, Breedveld PC, et al (1997) HuIL-10 in subjects with active rheumatoid arthritis (RA): a phase I and cytokine response study. Arthritis Rheum 40: S224

  57. Maksymowych W, Blackburn W, Hutchings E, Williams L, Tami J, Wagner K Shanahan W (1999) A pilot study of ISIS 2302: an antisense nucleotide in patients with active RA. Arthritis Rheum 42: S170

  58. Malfait AM, et al (1998) Blockade of IL-12 during the induction of collagen-induced arthritis markedly attenuates the severity of the arthritis. Clin Exp Immunol 111: 377

    Article  PubMed  CAS  Google Scholar 

  59. Matis LA, Rollins SA (1995) Complement-specific antibodies: designing novel anti-inflammatories. Nat Med 1:839

    Article  PubMed  Google Scholar 

  60. Matsumoto AK, Moreland LW for the. Study Group, Strand V, Morgan EE, Nardo CJ, Richieri SP, Brostoff SW (1999) Results of a phase IIB rheumatoid arthritis clinical trial using T cell receptor peptides. Arthritis Rheum 42:S117

  61. Mauri C, Williams RO, Walmsley M, Feldmann M (1996) Relationship between Th1/Th2 cytokine patterns and the arthritogenic response in collagen-induced arthritis. Eur J Immunol 26:1511

    Article  PubMed  CAS  Google Scholar 

  62. McKown KM, Carbone LD, Bustillo J, Seyer JM, et al (2000) Induction of immune tolerance to human type I collagen in patients with systemic sclerosis by oral administration of bovine type I collagen. Arthritis Rheum 43:1054

    Article  PubMed  CAS  Google Scholar 

  63. Merino J, Revilla C, Conde C, et al (1994) The effects of the treatment with anti-LFA-la or anti-ICAM-1 mAb on the tolerance and autoimmunity in mice injected at birth with Fl hybrid cells depends on the saturation of these molecules in different lymphoid organs. Arthritis Rheum 37:S390

    Google Scholar 

  64. Milkacz K, Brennan FR, Kim JH, et al (1994) Immunotherapy with antibodies to cell adhesion molecules in proteoglycan-induced arthritis. Arthritis Rheum 37:S397

    Google Scholar 

  65. Miotla JM, Paleolog E, Maciewicz R, Kendrew J, et al (1999) Blockade of vascular endothelial growth factor activity attenuates murine collagen-induced arthritis. Arthritis Rheum 42:S121

    Google Scholar 

  66. Mohan C, Shi Y, Laman JD, Datta SK (1995) Interaction between CD40 and its ligand gp39 in the development of murine lupus nephritis. J Immunol 154:1470

    PubMed  CAS  Google Scholar 

  67. Mojcik CF, Shevach EM. (1997) Adhesion molecules: a rheumatologic perspective. Arthritis Rheum 40:991

    Article  PubMed  CAS  Google Scholar 

  68. Moreland LW, Morgan EE, Adamson TC III, Calabrese LH, et al (1998) T cell receptor peptide vaccination in rheumatoid arthritis: a placebo controlled trial using a combination of Vb3, 14 and 17 peptides. Arthritis Rheum 41:1919

    Article  PubMed  CAS  Google Scholar 

  69. Morita Y, et al (1998) Expression of IL-12 in synovial tissue from patients with RA. Arthritis Rheum 41:306

    Article  PubMed  CAS  Google Scholar 

  70. Mosmann TR, Sad S (1996) The expanding universe of T cell subsets: TH1, Th2 and more. Immunol Today 17:13

    Article  Google Scholar 

  71. Muller-Ladner U, Franklin B, Roberts C et al (1996) Gene transfer for IL-10 into human synovial fibroblasts and implantation into the SCID mouse. Arthritis Rheum 39: SI60

  72. Nagler-Anderson C, Bober LA, Robinson ME, et al (1986) Suppression of type II collagen-induced arthritis by intragastric administration of soluble type II collagen. Proc Natl Acad Sei USA 83:7443

    Article  CAS  Google Scholar 

  73. Nakajima T, Hono H, Hasunuma T, et al (1995) Apoptosis and functional fas antigen in RA synoviocytes. Arthritis Rheum 38: 485

    Article  PubMed  CAS  Google Scholar 

  74. Neurath MF, et al (1995) Antibodies to interleukin 12 abrogate established experimental colitis in mice. J Exp Med 182:1281

    Article  PubMed  CAS  Google Scholar 

  75. Oliver SJ, Cheng TP, Banquerigo ML, Brahn E (1995) Suppression of collagen induced arthritis by an angiogenesis inhibitor, AGM-1470, in combination with cyclosporin. Cell Immunol 166: 196

    Article  PubMed  CAS  Google Scholar 

  76. Paliard X, West SG, Lafferty J, et al (1991) Evidence for the effects of a superantigen in rheumatoid arthritis. Science 253:325

    Article  PubMed  CAS  Google Scholar 

  77. Park Y, Lee SK, Kim DS, et al (1998) Elevated interleukin-10 levels correlated with disease activity in systemic lupus erythematosus. Clin Exp Rheumatol 16:283

    PubMed  CAS  Google Scholar 

  78. Plater-Zyberk C, Hoogewerf AJ, Proudfoot AE, et al (1997) Effect of a CC chemokine receptor antagonist on collagen induced arthritis in DBA/1 mice. Immunol Lett 57:117

    Article  PubMed  CAS  Google Scholar 

  79. Pourie F, Menon S, Coffman RL (1993) Interleukin 4 and interleukin 10 are synergistic to inhibit cell-mediated immunity in vivo. Eur J Immunol 23:2223

    Article  Google Scholar 

  80. Prasad NKA, Papoff G, Zeuner A, et al (1998) Therapeutic preparations of normal polyspecific IgG (IVIg) induce apoptosis in human lymphocytes and monocytes: a novel mechanism of action of IVIg involving the fas apoptotic pathway. J Immunol 161:3781

    PubMed  CAS  Google Scholar 

  81. Probert L, Plows D, Kontogeorgos G, Kollias G (1995) The type I IL-1 receptor acts in series with TNF-α to induce arthritis in TNF-α transgenic mice. Eur J Immunol 25:1794

    Article  PubMed  CAS  Google Scholar 

  82. Racke MK, Bonomo A, Scott DE, et al (1994) Cytokine-induced immune deviation as a therapy for inflammatory autoimmune disease. J Exp Med 180:1961

    Article  PubMed  CAS  Google Scholar 

  83. Raz E, Dudler J, Lotz M, et al (1995) Modulation of disease activity in murine systemic lupus erythematosus by cytokine gene delivery. Lupus 4:286

    Article  PubMed  CAS  Google Scholar 

  84. Reiser H, Stadecker MJ (1996) Costimulatory B7 molecules in the pathogenesis of infectious and autoimmune diseases. N Engl J Med 335:1369

    Article  PubMed  CAS  Google Scholar 

  85. Rönnelid J, Nillson B (1998) Immune complexes from SLE sera induce IL-10 production. A possible vicious circle maintaining B cell hyperactivity in SLE. Arthritis Rheum 41:S67

    Google Scholar 

  86. Ruchatz H, Leung BP, Wei X-Q, McInnes IB, Liew FY (1998) Soluble IL-15 receptor alpha chain administration prevents murine collagen induced arthritis: a role for IL-15 in development of antigen induced immunopathology. J Immunol 160:5654

    PubMed  CAS  Google Scholar 

  87. Schulze-Koops H, Lipsky PE, Kavanaugh AF, Davis LS (1995) Elevated TH1- or THO-like cytokine mRNA in peripheral circulation of patients with rheumatoid arthritis, modulation by treatment with anti-ICAM-1 correlates with clinical benefit. J Immunol 155:5029

    PubMed  CAS  Google Scholar 

  88. Schulze-Koops H, Lipsky PE, Kavanaugh AF, Davis LS (1996) Persistent reduction in IL-6 mRNA in peripheral blood mononuclear cells of patients with rheumatoid arthritis responding to treatment with a monoclonal antibody to CD54 (ICAM-1). Clin Exp Immunol 106:190

    Article  PubMed  CAS  Google Scholar 

  89. Souza D, Raymond E, Nabozny G, Ridgefiled CT (1999) Synergistic inhibition of collagen induced arthritis through dual inhibition of ICAM-1 and CD40L pathways. Arthritis Rheum 42: S124

  90. St Clair EW, Cohen SB, Lee ML, Fleischmann RM, et al (2000) Treatment of rheumatoid arthritis with a DR4/1 peptide. J Rheumatol 27:1855

    PubMed  CAS  Google Scholar 

  91. Strand V (1996) The future use of biological agents in combination for treatment of rheumatoid arthritis. J Rheumatol 23: 91

    Google Scholar 

  92. Struyk L, Hawes GE, Chatila MK, et al (1995) T cell receptors in rheumatoid arthritis. Arthritis Rheum 38:577

    Article  PubMed  CAS  Google Scholar 

  93. Szekanecz Z, Strieter RM, Kunkel SL, Koch AE (1998) Chemokines in rheumatoid arthritis. Springer Semin Immunopathol 20:115

    Article  PubMed  CAS  Google Scholar 

  94. Trinchieri G (1998) Proinflammatory and immunoregulatory functions of IL-12. Int Rev Immunol 16:365

    Article  PubMed  CAS  Google Scholar 

  95. Van Roon JAG, Roy JLAM van, Gmelig-Meyling FHJ, et al (1996) Prevention and reversal of cartilage degradation in rheumatoid arthritis by IL-10 and IL-4. Arthritis Rheum 39: 829

    Article  PubMed  Google Scholar 

  96. Wang D, Reddy B, Mihara M, et al (2000) Mechanism of action of short term combination of CTLA4Ig/CD40L therapy in murine SLE. Arthitis Rheum 43:S92

    Google Scholar 

  97. Wang Y, Hu Q, Madre JA, et al (1996) Amelioration of lupus-like autoimmune disease in NZB/W Fl mice after treatment with a blocking monoclonal antibody specific for complement component C5. Proc Natl Acad Sei USA 93:8563

    Article  CAS  Google Scholar 

  98. Wang Y, Hu O, Kristan J et al (1996) Subcutaneous administration of anti-C5 monoclonal antibody induces systemic complement inhibition and ameliorates immune complex mediated inflammatory responses. Arthritis Rheum 39:S245

    Google Scholar 

  99. Whalen J, Carlos CA, Robbins P, et al (1997) Periarticular gene therapy with viral IL-10 can prevent collagen-induced arthritis in mice. Arthritis Rheum 40: S158

  100. Williams RO, Feldmann M, Maini RN (1992) Anti-TNF meliorates joint disease in murine collagen induced arthritis. Proc Natl Acad Sei USA 89:9784

    Article  CAS  Google Scholar 

  101. Wooley PH, Luthra HS, Lafuse WP, e al (1985) Type II collagen-induced arthritis in mice. III. Suppression of arthritis by using monoclonal and polyclonal anti-la antisera. Immunology 134:2366

    CAS  Google Scholar 

  102. Yachyshyn BR, Bowen-Yacashyn MG, Jewell L, et al (1998) A placebo controlled trial of ICAM-1 antisense oligoneucleotide in the treatment of Crohn’s disease. Gastroenterology 114:1133

    Article  Google Scholar 

  103. Yellin MJ, D’Agati V, Parkinson G, et al (1997) Immunohistologic analysis of renal CD40 and CD40L expression in lupus nephritis and other glomerulonephritides. Arthritis Rheum 40:124

    Article  PubMed  CAS  Google Scholar 

  104. Zang ZJ, Lee CS, Lider O, et al (1990) Suppression of adjuvant arthritis in Lewis rats by oral administration of type II collagen. J Immunol 145:2489

    Google Scholar 

  105. Zhang H, Yang Y, Horton JL, et al (1997) Amelioration of collagen-induced arthritis by CD95 (Apo-l/Fas)-ligand expressing APCs as a therapy of autoimmune disease. J Clin Invest 100: 1951

    Article  PubMed  CAS  Google Scholar 

  106. Zuniga-Pflucker JC, Jiang D, Leonardo MJ (1995) Requirement for TNF-α and IL-1α in fetal thymocyte commitment and differentiation. Science 268: 1906

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Clinical Faculty (VCF), Division of Immunology, Stanford University School of Medicine, 306 Ramona Road, 94028, Portola Valley, CA, USA

    Vibeke Strand

Authors
  1. Vibeke Strand
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Strand, V. New therapies in development for autoimmune diseases: their rationale for combination treatment. Springer Semin Immunopathol 23, 43–61 (2001). https://doi.org/10.1007/s002810100071

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s002810100071

Keywords

Search

Navigation